Delaware Critiques Conventional BV Models for Valuing an Emerging, Short-Lived Niche Company But Goes With DCF

Business Valuation UpdateVol. 10 No. 11
Legal and Court Case Update
November 2004

Access the Full Article

This article is available with a subscription to any of these products:
Already a subscriber?  Login
This article is also available for purchase. (1,987 words)   Add to Cart >>
Need help? Contact us:
1-503-479-8200 ext 2 or sales@bvresources.com
shareholder dissent/oppression
Lane v. Cancer Treatment Centers of America, Inc.
No. 12207 (Del. Chan. 2004)
July 30, 2004
US
State Court
Delaware
Court of Chancery
Thomas P. White
Richard S. Baehr <br> Robert J. Cimasi, ASA <br>
Noble

Summary

The issue in this appraisal action, filed by Robert Michael Lane, was the fair value of the common stock of Cancer Treatment Centers of America Inc. (CTCA or the Company).

See Also

Lane v. Cancer Treatment Centers of America, Inc.

Full Text of Court Cases
July 30, 2004

The Delaware Court of Chancery determined the fair value of a closely held, subchapter S corporation’s stock. The primary reason for the great differences in value determined by the opposing experts in this case resulted from the assumptions regarding the ...